ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0063

Deriving Kidney Function from Medical Images for Patients Affected by Polycystic Kidney Disease Using Multitask Deep Learning

Session Information

Category: Artificial Intelligence, Digital Health, and Data Science

  • 300 Artificial Intelligence, Digital Health, and Data Science

Authors

  • Dhar, Mrinal Kanti, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Gregory, Adriana, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Buchl, Samuel, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Holmes, Heather L., Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Green, Abigail, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Fati, Francesca, Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Kline, Timothy L., Mayo Clinic Minnesota, Rochester, Minnesota, United States
Background

Clinically significant chronic kidney disease (CKD) is typically identified using serum creatinine-derived estimated glomerular filtration rate (eGFR), not imaging. This project investigates whether MR images contain sufficient imaging information to distinguish between patients with relatively preserved kidney function and those with reduced renal function.

Methods

Deep learning models were trained on 2300 MRIs and evaluated on an independent test set of 576 MRIs (classes 0/1: 347/229). Class labels were defined using eGFR: class 0 (eGFR ≥60 mL/min/1.73 m2) and class 1 (eGFR<60). This threshold was chosen to separate healthy to milder disease from moderate to advanced functional impairment. Four strategies were compared against a ResNet18 baseline: (1) multi-task learning (regression & classification); (2) multi-modal multi-task learning by adding age and/or sex; (3) multi-image learning combining whole-image and kidney ROI embeddings; and (4) ensemble network (ResNet18 & VGG16).

Results

The baseline model achieved 0.65 accuracy and 0.76 AUC. Among multi-task models, the two-head joint regression-classification model performed best, achieving 0.81 accuracy, 0.77 F1 score, and 0.89 AUC. In the multi-modal setting, adding sex improved performance (0.79 accuracy, 0.76 F1, 0.87 AUC), while age alone showed low sensitivity (0.31). Combining whole-image and kidney ROI features outperformed ROI-only images (0.71 vs. 0.66 accuracy; 0.77 vs. 0.71 AUC). The ensemble network achieved the highest overall performance (accuracy 0.83, AUC 0.92, sensitivity 0.88, and F1 score 0.81).

Conclusion

An MR-based CKD classifier could enable noninvasive, opportunistic identification of clinically significant CKD from routinely acquired imaging and reduce dependence on contemporaneous serum creatinine testing for screening or triage.

Funding

  • Private Foundation Support